Log in to your Inderes Free account to see all free content on this page.
Xvivo Perfusion
287.80 SEK
+2.35 %
Less than 1K followers
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+2.35 %
+2.79 %
+55.48 %
+54.23 %
+75.38 %
-13.57 %
-0.76 %
-6.10 %
+1,414.74 %
Xvivo Perfusion operates in the medical technology industry and focuses on the development and manufacturing of systems for organ transplantation and perfusion. Examples of products that the company supplies include cannulas, organ storage and cooling solutions. The company's products are aimed at healthcare institutions and surgeons. Xvivo Perfusion operates globally, was founded in 1998 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
9.07B SEK
Turnover
6.78M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
14.7.
2026
Interim report Q2'26
22.10.
2026
Interim report Q3'26
28.1.
2027
Annual report '26
All
Webcasts
Press releases
ShowingAll content types
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
Xvivo, Audiocast, Q1'26
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
